Bank Of New York Mellon Corp Beam Therapeutics Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$30.15 - $48.79 $14.4 Million - $23.2 Million	476,393 New	476,393 $14.6 Billion
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $18.1 Million - $25.4 Million	492,711 New	492,711 $19.3 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $1.14 Million - $2.02 Million	28,764 Added 6.08%	502,008 $23.9 Million
Q2 2022 Aug 15, 2022	BUY	$29.86 - $62.36 $6.74 Million - $14.1 Million	225,868 Added 91.31%	473,244 $18.3 Million
Q1 2022 May 11, 2022	SELL	$53.73 - $82.16 $119,925 - $183,381	-2,232 Reduced 0.89%	247,376 $14.2 Million
Q4 2021 Feb 11, 2022	BUY	$68.02 - $99.06 $552,934 - $805,258	8,129 Added 3.37%	249,608 $19.9 Million
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $2.22 Million - $3.51 Million	26,304 Added 12.22%	241,479 $21 Million
Q2 2021 Aug 11, 2021	BUY	$64.12 - $128.71 $2.8 Million - $5.63 Million	43,707 Added 25.49%	215,175 $27.7 Million
Q1 2021 May 13, 2021	SELL	$71.28 - $120.75 $2.17 Million - $3.68 Million	-30,496 Reduced 15.1%	171,468 $13.7 Million
Q4 2020 Feb 09, 2021	BUY	$22.24 - $95.63 $1.25 Million - $5.39 Million	56,398 Added 38.74%	201,964 $16.5 Million
Q3 2020 Nov 12, 2020	BUY	$19.0 - $30.57 $1.2 Million - $1.92 Million	62,922 Added 76.14%	145,566 $3.58 Million
Q2 2020 Aug 12, 2020	BUY	$15.26 - $28.66 $919,002 - $1.73 Million	60,223 Added 268.6%	82,644 $2.31 Million
Q1 2020 May 06, 2020	BUY	$13.31 - $29.2 $298,423 - $654,693	22,421 New	22,421 $403,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.04B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.